Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $211,716 - $238,456
-3,668 Closed
0 $0
Q1 2022

Apr 06, 2022

BUY
$57.92 - $72.58 $14,827 - $18,580
256 Added 7.5%
3,668 $218,000
Q4 2021

Jan 27, 2022

BUY
$64.88 - $73.64 $28,417 - $32,254
438 Added 14.73%
3,412 $248,000
Q3 2021

Nov 01, 2021

BUY
$67.69 - $73.03 $1,963 - $2,117
29 Added 0.98%
2,974 $208,000
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $186,919 - $204,235
2,945 New
2,945 $203,000
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $198,275 - $225,925
-3,500 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $32,540 - $40,913
-524 Reduced 13.02%
3,500 $221,000
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $13,165 - $15,288
-182 Reduced 4.33%
4,024 $310,000
Q1 2020

May 07, 2020

BUY
$62.63 - $80.22 $263,421 - $337,405
4,206 New
4,206 $314,000
Q4 2019

Feb 06, 2020

SELL
$61.62 - $67.78 $262,686 - $288,946
-4,263 Closed
0 $0
Q3 2019

Oct 24, 2019

BUY
$62.51 - $69.0 $15,377 - $16,974
246 Added 6.12%
4,263 $270,000
Q2 2019

Aug 06, 2019

BUY
$61.87 - $69.38 $5,320 - $5,966
86 Added 2.19%
4,017 $271,000
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $245,805 - $275,366
3,931 New
3,931 $256,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cedar Brook Financial Partners, LLC Portfolio

Follow Cedar Brook Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.